Symbols / CLYM Stock $8.88 +1.14% Climb Bio, Inc.

Healthcare • Biotechnology • United States • NGM
CLYM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Aoife M. Brennan BAO, BCh, M.D., MB, …
Exch · Country NGM · United States
Market Cap 424.18M
Enterprise Value 323.64M
Income -59.85M
Sales —
FCF (ttm) -33.32M
Book/sh 3.36
Cash/sh 2.12
Employees 28
Insider 10d —
IPO Aug 10, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -6.08
PEG —
P/S —
P/B 2.64
P/C —
EV/EBITDA -4.77
EV/Sales —
Quick Ratio 14.47
Current Ratio 15.16
Debt/Eq 0.34
LT Debt/Eq —
EPS (ttm) -0.88
EPS next Y -1.46
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-05
Earnings (prior) 2026-03-05
ROA -22.04%
ROE -32.15%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 47.77M
Shs Float 28.06M
Insider Own 0.37%
Instit Own 63.57%
Short Float 9.90%
Short Ratio 3.29
Short Interest 1.61M
52W High 10.10
vs 52W High -12.08%
52W Low 1.13
vs 52W Low 685.84%
Beta -0.20
Impl. Vol. 6.25%
Rel Volume 1.62
Avg Volume 621.60K
Volume 1.00M
Target (mean) $16.25
Tgt Median $16.00
Tgt Low $8.00
Tgt High $26.00
# Analysts 12
Recom Strong_buy
Prev Close $8.78
Price $8.88
Change 1.14%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-12.56
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest CLYM news

No recent news from Yahoo. Try the RSS feed for latest CLYM news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-26 THOMAS STEPHEN BASIL Director — 50,000 $7.00 $350,253
2026-02-13 THOMAS STEPHEN BASIL Director — 100,000 $5.23 $529,129
2026-01-05 RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security — 7,111 $3.50 $24,888
2025-12-12 RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security — 314,561 $2.18 $754,737
2025-08-07 THOMAS STEPHEN BASIL Director — 100,375 $0.00 $0
2025-06-30 BRENNAN AOIFE M Chief Executive Officer — 20,618 $1.22 $25,154
2025-06-27 BRENNAN AOIFE M Chief Executive Officer — 68,750 — —
2025-06-27 THOMAS STEPHEN BASIL Director — 25,094 — —
2025-06-20 PIMBLETT EMILY Officer — 1,242 $1.24 $1,540
2025-06-18 PIMBLETT EMILY Officer — 5,000 — —
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category